Skip to main content
Have a personal or library account? Click to login
Localised gastrointestinal diffuse large B cell lymphomas; Does surgical approach still exist? Cover

Localised gastrointestinal diffuse large B cell lymphomas; Does surgical approach still exist?

Forum of Clinical Oncology
Volume 6 (2015): Issue 1 (March 2015)
By: ,   and    
Open Access
|Mar 2015
References

References

  1. [1] Psyrri1 A, Papageorgiou S & Economopoulos T; Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management Annals of Oncology 19: 1992-1999, 2008
    Open DOISearch in Google Scholar
  2. [2] Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol 136: 521-538, 2007
    Open DOISearch in Google Scholar
  3. [3] Cogliatti SB, Schmid U, Schumacher U et al; . Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 1991; 101: 1159-1170.
    Open DOISearch in Google Scholar
  4. [4] National Comprehensive Cancer Network. http:// www.nccn.org/gls.PDF. Accessed January 10th, 2014.
    Search in Google Scholar
  5. [5] Kim S, Kang H, Kim J, et al; Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. blood 117: 1958-1965,2011
    Open DOISearch in Google Scholar
  6. [6] Daum S, Ullrich R, Heise W, et al. Intestinal non- Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol.;21(14):2740-2746.2003
    Open DOISearch in Google Scholar
  7. [7] Lee J, Kim WS, Kim K, et al. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma. ;45(2):339-344,2004
    Search in Google Scholar
  8. [8] Tanaka T, Shimada K, Yamamoto K, et al; Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan. Ann Hematol. Mar;91(3):383-90,2012
    Open DOISearch in Google Scholar
  9. [9] Li X, Shen W, Cao J et al; Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases. Ann Hematol. 91:1721-9,2012
    Open DOISearch in Google Scholar
  10. [10] Brands F, Mönig SP, Raab M: Treatment and prognosis of gastric lymphoma. Eur J Surg 163:803-813, 1997
    Search in Google Scholar
  11. [11] Fischbach W, Dragosics B, Kolve Gobeler ME, et al: Primary gastric B-cell-lymphoma: Results of a prospective multicenter study. Gastroenterology 119:1191-1202, 2000
    Open DOISearch in Google Scholar
  12. [12] Rodríguez-Sanjuán J , García R, Trugeda S, et al; Do current indications for surgery of primary gastric lymphoma exist? Rev Esp Enferm Dig (Madrid) 98. 180-188,2006
    Open DOISearch in Google Scholar
  13. [13] Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 23(28):7050-7059.2005
    Open DOISearch in Google Scholar
  14. [14] Sohn BS, Kim SM, Yoon DH,et al; The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma. Ann Hematol. 91:1731-9.2012.
    Open DOISearch in Google Scholar
  15. [15] Rohatiner A, d’Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 5:397- 400.1994
    Open DOISearch in Google Scholar
  16. [16] Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 47:207-214. 1981
    Open DOISearch in Google Scholar
  17. [17] Kaplan EL, Meier P , Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53:457-481.
    Open DOISearch in Google Scholar
  18. [18] Ghimire P, Wu G, Zhu L ;Primary gastrointestinal lymphoma World J Gastroenterol; 17: 697-707 2011
    Open DOISearch in Google Scholar
  19. [19] Kim SJ, Choi CW, Mun YC, et al,. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL) BMC Cancer 11:321, 2011
    Open DOISearch in Google Scholar
  20. [20] d’Amore F, Brincker H, Gronbaek K, et al; Non- Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol 12:1673-1684. 1994
    Open DOISearch in Google Scholar
  21. [21] Ko YH, Kim CW, Park CS, et al; REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European- American lymphoma. Cancer , 83:806-812. 1998
    Open DOISearch in Google Scholar
  22. [22] Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M: Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 97:2462-2473. 2003
    Open DOISearch in Google Scholar
  23. [23] Brands F, Mönig SP, Raab M: Treatment and prognosis of gastric lymphoma. Eur J Surg 163:803-813, 1997
    Search in Google Scholar
  24. [24] De Jong D, Aleman BM, Taal BG, et al: Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey. Ann Oncol 10:275-280, 1999.
    Open DOISearch in Google Scholar
  25. [25] Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, Grothaus-Pinke B, Reinartz G, Brockmann J, Temmesfeld A, et al: Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 19:3861-3873, 2001
    Open DOISearch in Google Scholar
  26. [26] O H D, Choi IS, Kim JH, et al; Management of gastric lymphoma with chemotherapy alone. Leuk Lymphoma. 46:1329-35. 2005.
    Open DOISearch in Google Scholar
  27. [27] Lee J, Kim WS, Kim K, et al; prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res.;31:359-364. 2007.
    Open DOISearch in Google Scholar
  28. [28] Daum S, Ullrich R, Heise W, et al. Intestinal non- Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol.;21):2740-2746. 2003
    Open DOISearch in Google Scholar
  29. [29] Ibrahim EM, Ezzat AA, Raja MA et al. Primary gastric non-Hodgkin’s lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma. Ann Oncol1999; 10: 1441-1449.
    Open DOISearch in Google Scholar
  30. [30] Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97(10):2462-2473.
    Open DOISearch in Google Scholar
  31. [31] Lee J, Kim WS, Kim K, et al. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma. 2004;45(2):339-344.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/fco-2015-0003 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 10 - 17
Published on: Mar 25, 2015
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Keywords:
Gastrontestinal lymphoma,
DLBCL,
Surgery,
Chemotherapy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2015 Abeer Ibrahim, Ali Zedan, Alia M. A. Attia, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 6 (2015): Issue 1 (March 2015)
Previous article
Next article